Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
Operating Expenses | 1,092 | 1,315 | 913 | 1,279 | 0 |
Operating Income | -1,092 | -1,315 | -913 | -1,279 | N/A |
Other Income | -1 | 0 | 0 | 0 | 0 |
Pre-tax Income | -1,093 | -1,315 | -913 | -1,279 | 0 |
Net Income Continuous | -1,093 | -1,315 | -913 | -1,279 | N/A |
Net Income | $-1,093 | $-1,315 | $-913 | $-1,279 | $N/A |
EPS Basic Total Ops | -0.16 | -0.21 | -0.15 | -0.22 | N/A |
EPS Basic Continuous Ops | -0.16 | -0.21 | -0.15 | -0.22 | N/A |
EPS Diluted Total Ops | -0.16 | -0.21 | -0.15 | -0.22 | N/A |
EPS Diluted Continuous Ops | -0.16 | -0.21 | -0.15 | -0.22 | N/A |
EBITDA(a) | $-1,092 | $-1,315 | $-913 | $-1,279 | $N/A |